Using Big Data for Bioengineering Antibodies and Drug Discovery
Continue to learn about the cutting edge of computational immuno-oncology through a partnership between NCI and the Society for Immunotherapy of Cancer (SITC)!
In this webinar, Drs. Liz Wood, founder and CEO of JURA Bio, Inc., and Sandhya Prabhakaran, of the Moffitt Cancer Center, will discuss how to use big data for bioengineering antibodies and drug discovery in cancer research.
The SITC-NCI Computational Immuno-Oncology Webinar Series features eight, one-hour-long webinars designed to educate early-career scientists on computational immuno-oncology, increase participants’ awareness of and engagement in NCI-supported Cancer MoonshotSM Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.
Dr. Wood is the co-founder and CEO of JURA Bio, Inc., an early-stage therapeutics company focused on developing and delivering cell-based therapies for treating autoimmune and immune-related neurodegenerative diseases.
Dr. Prabhakaran is an applied research scientist at the Integrated Mathematical Oncology Department of the Moffitt Cancer Centre.
Upcoming Events
- Agentic AI in Cancer ResearchMay 27, 2025BTEC 2025 Annual Conference: The Epidemiology of Brain Metastases for Adult and Pediatric Brain TumorsMay 29, 2025Ctrl+Alt+Cure: Driving Smarter Cancer CareJune 11, 2025NCI Emerging Technologies Seminar: Programs and Resources to Support Technology Development for Cancer ResearchJune 17, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025